Table 2 Adverse reactions of the experimental and control groups
From: Remote-controlled cholangiography injection device: first clinical study in China
Diseases | Groups | Numbers | P value | |
|---|---|---|---|---|
With adverse reactions | Without adverse reactions | |||
Biliary Calculi | Experimental group | 8 | 168 | 0.008 |
Control group | 25 | 180 | ||
Hepato-Bilio-Pancreatic Cancer | Experimental group | 1 | 30 | 0.086 |
Control group | 4 | 20 | ||
Liver transplantation | Experimental group | 1 | 22 | > 0.999 |
Control group | 1 | 13 | ||
Other | Experimental group | 0 | 21 | 0.111 |
Control group | 2 | 9 | ||
Total | Experimental group | 10 | 240 | 0.001 |
Control group | 31 | 223 | ||